Male contraception showed promise in study
An experimental drug that temporarily stops sperm in their tracks could be a “game-changer” for contraception, a new study found.
An experimental drug that temporarily stops sperm in their tracks could be a “game-changer” for contraception, a new study found.
Living with Angelman Syndrome: A Minnesota family's tale
Rose Smith, a 5-year-old New Brighton girl, is one of 160 Minnesotans with Angelman Syndrome, a rare neurogenic disorder that impacts about one in 15,000 to 20,000 people worldwide.
Rose Smith, a 5-year-old New Brighton girl, is one of 160 Minnesotans with Angelman Syndrome, a rare neurogenic disorder that impacts about one in 15,000 to 20,000 people worldwide.
Anoka ammunition site workers' children should be tested for lead: MDH
Minnesota health officials are urging workers at the Federal Ammunition plant in Anoka to have their children tested after several children in separate homes were found to have elevated blood lead levels.
Minnesota health officials are urging workers at the Federal Ammunition plant in Anoka to have their children tested after several children in separate homes were found to have elevated blood lead levels.
Revitalizing old blood with anti-inflammatory drug could slow aging, study suggests
The new study focused on an anti-inflammatory drug used for rheumatoid arthritis and found that it may reverse some of the effects of aging on the blood system in mice.
The new study focused on an anti-inflammatory drug used for rheumatoid arthritis and found that it may reverse some of the effects of aging on the blood system in mice.
Parents want natural remedies for son’s leukemia, child protection wants chemo
The couple's son went through one round of chemo after being diagnosed with leukemia. Now, they are fighting in court to prevent future treatments, preferring to treat their child with natural remedies — while the hospital insists on a two-year regimen.
The couple's son went through one round of chemo after being diagnosed with leukemia. Now, they are fighting in court to prevent future treatments, preferring to treat their child with natural remedies — while the hospital insists on a two-year regimen.
SOTU: Biden pushes for insulin cost caps
Democrats tried to cap the price of insulin last year when they controlled both houses and fell short of the votes needed.
Democrats tried to cap the price of insulin last year when they controlled both houses and fell short of the votes needed.
‘Intensive’ blood pressure treatment could reduce dementia risk: study
The study found that intensive blood pressure treatment may help to clear toxins and other byproducts from the brain.
The study found that intensive blood pressure treatment may help to clear toxins and other byproducts from the brain.
Proposed Massachusetts bill would reduce inmate sentences if they donate organs
If passed, eligible individuals who are behind bars in Massachusetts could receive 60 days to one year off of their sentences in exchange for donating organs or bone marrow.
If passed, eligible individuals who are behind bars in Massachusetts could receive 60 days to one year off of their sentences in exchange for donating organs or bone marrow.
Satanic Temple launches telehealth abortion care in New Mexico, hopes to expand
The Satanic Temple, which doesn’t believe in a literal Satan, has claimed its abortion ritual is exempt from bans because it’s part of religious practice.
The Satanic Temple, which doesn’t believe in a literal Satan, has claimed its abortion ritual is exempt from bans because it’s part of religious practice.
Abortion in Minnesota: Gov. Tim Walz signs abortion bill into law
On Tuesday, Jan. 31, Gov. Tim Walz signed an abortion bill into law in Minnesota. The new law guarantees abortion access in state law.
On Tuesday, Jan. 31, Gov. Tim Walz signed an abortion bill into law in Minnesota. The new law guarantees abortion access in state law.
Fairview-Sanford merger: CEOs rebuff calls for delay from AG, U of M, lawmakers
The leaders of Fairview Health Services and Sanford Health said Monday that they want to close their proposed merger by the end of March despite opposition and concern at the state Capitol
The leaders of Fairview Health Services and Sanford Health said Monday that they want to close their proposed merger by the end of March despite opposition and concern at the state Capitol
FDA eases rules for gay men to donate blood
Gay rights groups have long opposed blanket restrictions on who can give blood, saying they discriminate against the LGBTQ community.
Gay rights groups have long opposed blanket restrictions on who can give blood, saying they discriminate against the LGBTQ community.
Xylazine reaches Minnesota: officials concerned by fentanyl contaminated with animal sedative
Public health officials in Minnesota are growing increasingly concerned about Xylazine, a powerful animal sedative known by the street name “tranq” that is being mixed with the local illicit fentanyl supply.
Public health officials in Minnesota are growing increasingly concerned about Xylazine, a powerful animal sedative known by the street name “tranq” that is being mixed with the local illicit fentanyl supply.
Minnesotan who lost eyesight and leg now helps wounded Ukrainian soldiers
The Ukrainian soldiers who come to Minnesota to be fitted with prosthetic limbs have been face a long road to recovery. In that journey, they have an unlikely source of inspiration: a blind woman from Eden Prairie who knows a thing or two about adjusting to sudden setbacks.
The Ukrainian soldiers who come to Minnesota to be fitted with prosthetic limbs have been face a long road to recovery. In that journey, they have an unlikely source of inspiration: a blind woman from Eden Prairie who knows a thing or two about adjusting to sudden setbacks.
Minnesota closing state-run COVID-19 testing sites
The state of Minnesota is closing its four remaining state-run COVID-19 testing sites this week.
The state of Minnesota is closing its four remaining state-run COVID-19 testing sites this week.
Fairview Southdale Hospital bans visitors for patient, investigation pending
Michael Puff, 71, has been at Fairview Hospital for 8 months with complex medical needs. On January 10, his family received a letter from M Health Fairview, informing them they would no longer be allowed to visit him unless they were taking him from the hospital.
Michael Puff, 71, has been at Fairview Hospital for 8 months with complex medical needs. On January 10, his family received a letter from M Health Fairview, informing them they would no longer be allowed to visit him unless they were taking him from the hospital.
University of Minnesota plans to retake control of its medical facilities, build new hospital
A big proposal came from the University of Minnesota on Thursday to take back ownership of its medical facilities and build a new hospital.
A big proposal came from the University of Minnesota on Thursday to take back ownership of its medical facilities and build a new hospital.
Need for volunteers to help hospice care patients greater than ever
Each and every Wednesday, volunteer Sheila Johnson wears many hats inside Brooklyn Park's J.A. Wedum Residential Hospice.
Each and every Wednesday, volunteer Sheila Johnson wears many hats inside Brooklyn Park's J.A. Wedum Residential Hospice.
New Alzheimer's drug: What to know as Leqembi hits the market
Here are some things to know about the FDA's approval of lecanemab, to be sold under the brand name Leqembi.
Here are some things to know about the FDA's approval of lecanemab, to be sold under the brand name Leqembi.
FDA considering accelerated approval of new Alzheimer’s drug
The FDA is considering accelerated approval of a new drug shown to attack amyloid plaque in the human brain, a contributing cause of cognitive dysfunction in dementia and Alzheimer’s disease. The FDA is expected to reach a decision by Friday, January 6.
The FDA is considering accelerated approval of a new drug shown to attack amyloid plaque in the human brain, a contributing cause of cognitive dysfunction in dementia and Alzheimer’s disease. The FDA is expected to reach a decision by Friday, January 6.